首页> 外文OA文献 >Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies.
【2h】

Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies.

机译:性激素和绝经前女性患乳腺癌的风险:来自七项前瞻性研究的个体参与者数据的协作性再分析。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: Associations between circulating concentrations of oestrogens, progesterone, and androgens with breast cancer and related risk factors in premenopausal women are not well understood. We aimed to characterise these associations with a pooled analysis of data from seven studies. METHODS: Individual participant data for prediagnostic sex hormone and sex hormone-binding globulin (SHBG) concentrations were contributed from seven prospective studies. We restricted analyses to women who were premenopausal and younger than 50 years at blood collection, and to women with breast cancer diagnosed before age 50 years. We estimated odds ratios (ORs) with 95% CIs for breast cancer associated with hormone concentrations by conditional logistic regression in cases and controls matched for age, date of blood collection, and day of cycle, with stratification by study and further adjustment for cycle phase. We examined associations of hormones with risk factors for breast cancer in control women by comparing geometric mean hormone concentrations in categories of these risk factors, adjusted for study, age, phase of menstrual cycle, and body-mass index (BMI). All statistical tests were two-sided. FINDINGS: We included data for up to 767 women with breast cancer and 1699 controls in the risk analyses. Breast cancer risk was associated with a doubling in concentrations of oestradiol (OR 1·19, 95% CI 1·06-1·35), calculated free oestradiol (1·17, 1·03-1·33), oestrone (1·27, 1·05-1·54), androstenedione (1·30, 1·10-1·55), dehydroepiandrosterone sulphate (1·17, 1·04-1·32), testosterone (1·18, 1·03-1·35), and calculated free testosterone (1·08, 0·97-1·21). Breast cancer risk was not associated with luteal phase progesterone (doubling in concentration OR 1·00, 95% CI 0·92-1·09), and adjustment for other factors had little effect on any of these ORs. Cross-sectional analyses in control women showed several associations of sex hormones with breast cancer risk factors. INTERPRETATION: Circulating oestrogens and androgens are positively associated with the risk for breast cancer in premenopausal women.
机译:背景:绝经前妇女中的雌激素,孕酮和雄激素的循环浓度与乳腺癌及相关危险因素之间的关联尚不十分清楚。我们旨在通过对七项研究的数据进行汇总分析来表征这些关联。方法:个人参与者的预诊断性激素和性激素结合球蛋白(SHBG)浓度数据来自七项前瞻性研究。我们将分析仅限于绝经前且血液采集年龄小于50岁的女性以及50岁之前被诊断患有乳腺癌的女性。我们通过与年龄,采血日期和周期天相匹配的病例和对照进行条件逻辑回归,估计了与激素浓度相关的乳腺癌与激素浓度相关的95%CI的优势比(OR),并通过研究进行了分层并进一步调整了周期阶段。我们通过比较这些危险因素类别中的几何平均荷尔蒙浓度(根据研究,年龄,月经周期阶段和身体质量指数(BMI)进行了调整),比较了对照女性中荷尔蒙与乳腺癌危险因素的关联。所有统计检验都是双面的。结果:我们在风险分析中纳入了多达767名乳腺癌女性和1699名对照女性的数据。乳腺癌风险与雌二醇浓度(OR 1·19,95%CI 1·06-1·35)加倍,游离雌二醇(1·17、1·03-1·33),雌酮(1 ·27,1·05-1·54),雄烯二酮(1·30,1·10-1·55),硫酸脱氢表雄酮(1·17,1·04-1·32),睾丸酮(1·18,1 ·03-1·35),并计算出游离睾丸激素(1·08、0·97-1·21)。黄体期孕酮与乳腺癌风险无关(浓度增加一倍,OR 1·00,95%CI 0·92-1·09),而调整其他因素对这些OR几乎没有影响。对照妇女的横断面分析显示,性激素与乳腺癌危险因素有多种关联。解释:绝经前妇女中循环中的雌激素和雄激素与患乳腺癌的风险呈正相关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号